MY173437A - A sanguisorba tannins extract, and preparation method and use thereof - Google Patents

A sanguisorba tannins extract, and preparation method and use thereof

Info

Publication number
MY173437A
MY173437A MYPI2013000864A MYPI2013000864A MY173437A MY 173437 A MY173437 A MY 173437A MY PI2013000864 A MYPI2013000864 A MY PI2013000864A MY PI2013000864 A MYPI2013000864 A MY PI2013000864A MY 173437 A MY173437 A MY 173437A
Authority
MY
Malaysia
Prior art keywords
extract
sanguisorba
preparation
content
less
Prior art date
Application number
MYPI2013000864A
Inventor
Ming Yang
Zhetong Su
Sheng Yang
Dabin Wang
Wenquan Zou
Original Assignee
Guangxi Innovate Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Innovate Pharmaceutical Co Ltd filed Critical Guangxi Innovate Pharmaceutical Co Ltd
Publication of MY173437A publication Critical patent/MY173437A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

A tannin extract of Sanguisorba officinalis L. contains tannin in a range of 35%-100% (w/w), wherein the content of total saponin is less than 10% (w/w), and the content of sanguisorbin I is less than 5% (w/w). The extract can protect bone marrow hematopoietic stem cells, relieve the inhibition of mouse bone marrow DNA caused by drugs for radiotherapy and chemotherapy, as well as increase numbers of leucocytes.
MYPI2013000864A 2010-09-14 2011-09-14 A sanguisorba tannins extract, and preparation method and use thereof MY173437A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010280772 2010-09-14
CN201110186932 2011-07-05

Publications (1)

Publication Number Publication Date
MY173437A true MY173437A (en) 2020-01-24

Family

ID=45831012

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013000864A MY173437A (en) 2010-09-14 2011-09-14 A sanguisorba tannins extract, and preparation method and use thereof

Country Status (5)

Country Link
CN (3) CN103948710A (en)
GB (1) GB2497899B (en)
MY (1) MY173437A (en)
SG (2) SG10201505752QA (en)
WO (1) WO2012034519A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103223036A (en) * 2013-04-16 2013-07-31 阚兆云 Traditional Chinese medicinal composition
CN104435220B (en) * 2013-09-22 2018-01-05 成都百草和济科技有限公司 Treat the combination medicine of bone marrow suppression
CN104623015A (en) * 2013-11-08 2015-05-20 成都百草和济科技有限公司 New application of garden burnet root and India madder root composition
GB201413228D0 (en) 2014-07-25 2014-09-10 Nugerontix Ltd Polyphenol compositions
CN105147804B (en) * 2015-08-28 2019-04-09 四川英路维特医药科技有限公司 A kind of radix sanguisorbae total saponin extract and its preparation method and application
US10155069B2 (en) 2016-09-09 2018-12-18 King Abdulaziz University Bone graft with a tannin-hydroxyapatite scaffold and stem cells for bone engineering
CN112876523B (en) * 2021-03-30 2023-07-25 江西海富生物工程有限公司 Method for recovering tannic acid from fructus momordicae, sweet tea or stevia rebaudiana floc residues
CN114577970B (en) * 2022-02-18 2023-05-12 江西普正制药股份有限公司 Method for establishing blood level tablet fingerprint and fingerprint thereof
CN115232516B (en) * 2022-06-27 2023-06-06 中南林业科技大学 Anti-adhesion coating with camellia saponin as main component, preparation method thereof and application thereof in inhibiting bacillus cereus
CN115998703B (en) * 2022-12-14 2024-09-06 迪沙药业集团有限公司 Sanguisorba composition and preparation method thereof
CN116688012B (en) * 2023-07-05 2024-06-04 浙江工业大学 Buccal tablet for preventing influenza

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103383A (en) * 1981-12-12 1983-06-20 Nippon Shinyaku Co Ltd New tannin
JPS58154571A (en) * 1982-03-08 1983-09-14 Nippon Shinyaku Co Ltd Novel tannin
CN1824631A (en) * 2005-12-29 2006-08-30 谢君 Molecular modification method of active fat soluble plant polyphenol kind substance
JP5528025B2 (en) * 2008-08-22 2014-06-25 花王株式会社 TG synthesis inhibitor

Also Published As

Publication number Publication date
GB201306569D0 (en) 2013-05-22
CN103079560A (en) 2013-05-01
CN103948710A (en) 2014-07-30
CN103784434A (en) 2014-05-14
SG188529A1 (en) 2013-04-30
GB2497899B (en) 2018-05-30
WO2012034519A1 (en) 2012-03-22
GB2497899A (en) 2013-06-26
SG10201505752QA (en) 2015-09-29

Similar Documents

Publication Publication Date Title
MY173437A (en) A sanguisorba tannins extract, and preparation method and use thereof
MX2010003934A (en) Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium.
WO2012024530A3 (en) Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
WO2012159085A3 (en) Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells
MX2013012151A (en) Method of inhibiting harmful microorganisms and barrier-forming composition therefor.
WO2012050396A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
WO2010095911A3 (en) Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient
Jing-hua et al. Effects of inoculating arbuscular mycorrhizal fungi on Artemisia annua growth and its officinal components.
MY183349A (en) Use of lanostane and poria extract in treating diabetes
WO2014138426A3 (en) Methods and compositions for reducing body fat and adipocytes
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
WO2009090394A3 (en) Composition containing capsicum for treating a skin disorder
NZ619634A (en) Therapeutic composition and uses thereof
CR20200218A (en) Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration
WO2013033365A3 (en) Stem cell compositions and methods
WO2012108749A3 (en) Composition and health functional food for treating brain cancer comprising pharbitidis semen extract
CN104446920A (en) Nutrient liquid capable of preventing and treating soft rot disease of dendrobium officinale
WO2011031890A3 (en) Cancer stem cell-targeted and drug resistant cancer therapy
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
CN104447081A (en) Nutrient solution for preventing and curing diaspididae of dendrobii officmalis caulis
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
WO2010129524A3 (en) Plant medicinal compounds
WO2012134250A3 (en) Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract